Evertor Tablets are a type of antineoplastic chemotherapy drugs that have shown high effectiveness against breast cancer, neuroendocrine tumors, and renal cell carcinoma. They are formulated having everolimus as active compound which is an inhibitor of mammalian target of rapamycin. Used as an immunosuppressant, Evertor Tablets prevent chances of organ transplant rejections by hyperactivation of kinase AKT with inhibition of mTORC1. They are also known to help in cell proliferation, survival, and growth.
Can also be given in combination with other cancer drugs
Has ability to improve progression free survival